Radiometal‐Labelled Macrocyclic Chelator‐Derivatised Somatostatin Analogue with Superb Tumour‐Targeting Properties and Potential for Receptor‐Mediated Internal Radiotherapy

Radiometal‐Labelled Macrocyclic Chelator‐Derivatised Somatostatin Analogue with Superb Tumour‐Targeting Properties and Potential for Receptor‐Mediated Internal Radiotherapy
复制标题

DOI:
10.1002/(sici)1521-3765(19990702)5:7
复制
发表时间:
1999-07
期刊:
Chemistry: A European Journal
影响因子:
--
通讯作者:
A. Heppeler;S. Froidevaux;H. Mäcke;E. Jermann;M. Béhé;P. Powell;M. Hennig
A. Heppeler;S. Froidevaux;H. Mäcke;E. Jermann;M. Béhé;P. Powell;M. Hennig
中科院分区:
其他
文献类型:
--
作者:
A. Heppeler;S. Froidevaux;H. Mäcke;E. Jermann;M. Béhé;P. Powell;M. Hennig

文献摘要

被引文献

相似文献